Yi Hui Wu
Chief Executive Officer at Hangzhou Puyang Investment Management Co., Ltd.
Net worth: 72 M $ as of 30/05/2024
Profile
Yi Hui Wu currently works at Zhejiang Tiansong Medical Instrument Co., Ltd., as Independent Director from 2019, Hangzhou Puyang Investment Management Co., Ltd., as General Manager & Executive Director from 2016, and Medtide, Inc., as Non-Executive Director from 2024.
Mr. Wu also formerly worked at Zhejiang Jindao Technology Co., Ltd., as Director.
Mr. Wu received his graduate degree from Zhejiang University of Finance & Economics.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/09/2023 | 10,363,914 ( 1.94% ) | 61 M $ | 30/05/2024 | |
| 30/12/2023 | 3,654,327 ( 4.04% ) | 11 M $ | 30/05/2024 |
Yi Hui Wu active positions
| Companies | Position | Start |
|---|---|---|
Hangzhou Puyang Investment Management Co., Ltd.
 Hangzhou Puyang Investment Management Co., Ltd. Investment ManagersFinance Hangzhou Puyang Investment Management Co., Ltd. provides investment management services. The company was founded on April 15, 2009 and is headquartered in Hangzhou, China. | Chief Executive Officer | 12/10/2016 |
Zhejiang Tiansong Medical Instrument Co., Ltd.
 Zhejiang Tiansong Medical Instrument Co., Ltd. Medical SpecialtiesHealth Technology Zhejiang Tiansong Medical Instrument Co., Ltd. engages in the research and development, production, and sale of endoscopic minimally invasive medical devices. Its products include abdominal surgery, orthopedic surgery, microsurgery, and gynecological endoscope minimally invasive medical equipment. The company was founded by Tian Song Xu and Tang Zhu Xu on August 28, 1998 and is headquartered in Hangzhou, China. | Director/Board Member | 15/09/2019 |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
 Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Director/Board Member | 31/12/2021 |
Former positions of Yi Hui Wu
| Companies | Position | End |
|---|---|---|
| ZHEJIANG JINDAO TECHNOLOGY CO., LTD. | Director/Board Member | - |
Training of Yi Hui Wu
| Zhejiang University of Finance & Economics | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
 | Health Technology |
| ZHEJIANG JINDAO TECHNOLOGY CO., LTD. | Distribution Services |
| Private companies | 2 |
|---|---|
Hangzhou Puyang Investment Management Co., Ltd.
Hangzhou Puyang Investment Management Co., Ltd. Investment ManagersFinance Hangzhou Puyang Investment Management Co., Ltd. provides investment management services. The company was founded on April 15, 2009 and is headquartered in Hangzhou, China. | Finance |
Taide Pharmaceutical (Zhejiang) Co., Ltd.
Taide Pharmaceutical (Zhejiang) Co., Ltd. BiotechnologyHealth Technology Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Shaoxing, China. | Health Technology |
- Stock Market
- Insiders
- Yi Hui Wu
